Butorphanol Tartrate (Hospira, Inc.)


Welcome to the PulseAid listing for the Butorphanol Tartrate drug offered from Hospira, Inc.. This Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: Butorphanol Tartrate
SUBSTANCE NAME: BUTORPHANOL TARTRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2005-09-23
END MARKETING DATE: 0000-00-00


Butorphanol Tartrate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionButorphanol Tartrate from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE: CIV
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2005-09-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-1623_5b7f62ee-abac-4d4e-bcbd-748d58641243
PRODUCT NDC: 0409-1623
APPLICATION NUMBER: ANDA074626

Other BUTORPHANOL TARTRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.Butorphanol Tartrate
Cardinal HealthButorphanol Tartrate
General Injectables & Vaccines, IncBUTORPHANOL TARTRATE
Hospira, Inc.Butorphanol Tartrate
Mylan Pharmaceuticals Inc.Butorphanol Tartrate
West-Ward Pharmaceuticals CorpButorphanol Tartrate
West-Ward Pharmaceuticals Corp.Butorphanol Tartrate